Related Experiment Video
Updated: Jul 19, 2026

07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
Rapid and efficient identification of epitopes/mimotopes from random peptide libraries
Xiaoli Yu1, Gregory P Owens, Donald H Gilden
1Department of Neurology, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Mail Stop B182, Denver, CO 80262, USA.
Journal of Immunological Methods
|October 3, 2006
Summary
This study introduces a rapid, high-throughput method for identifying phage peptides specific to multiple sclerosis (MS) recombinant monoclonal antibodies. The new technique significantly speeds up epitope discovery, aiding in the identification of MS-specific protein antigens.
Area of Science:
- Immunology
- Biotechnology
- Molecular Biology
Background:
- Phage-displayed random peptide libraries are crucial for identifying epitopes and mimotopes.
- Determining antigen specificity is key in understanding immune responses.
- Recombinant monoclonal antibodies (rAbs) from multiple sclerosis (MS) patients' cerebrospinal fluid offer insights into disease mechanisms.
Purpose of the Study:
- To develop a high-throughput method for determining phage specificity against rAbs.
- To expedite the identification of MS-specific peptides and their corresponding protein antigens.
Main Methods:
- Utilized phage-displayed random peptide libraries and affinity selection (panning).
- Developed a high-throughput method for phage specificity determination using ELISA on phage clones amplified in 96-well plates.
- Compared the new method with standard large-scale amplification techniques.
Main Results:
- The high-throughput method reduces phage specificity determination time from 8-9 days to 1 day.
- Direct amplification in 96-well plates eliminates the need for large-scale phage purification.
- Enables rapid identification of specific epitopes/mimotopes.
Conclusions:
- The developed high-throughput technique significantly accelerates the identification of MS-specific peptides.
- This method facilitates the discovery of novel epitopes/mimotopes and corresponding protein antigens relevant to multiple sclerosis.
- The approach streamlines research in autoimmune diseases like MS.

